HRT Financial’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

HRT Financial’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-48,400	Closed	-$14K	–	3362
2023 Q4	$14K	Sell	48,400 -1,215	-2%	-$375	﹤0.01%	2067
2023 Q3	$14K	Buy	49,615 +7	+0%	+$2	﹤0.01%	2101
2023 Q2	$7K	Sell	49,608 -7	-0%	-$1	﹤0.01%	2207
2023 Q1	$6K	Hold	49,615	–	–	﹤0.01%	2286
2022 Q4	$2K	Hold	49,615	–	–	﹤0.01%	2348
2022 Q3	$1K	Hold	49,615	–	–	﹤0.01%	2683
2022 Q2	$5K	Hold	49,615	–	–	﹤0.01%	2744
2022 Q1	$8K	Hold	49,615	–	–	﹤0.01%	2923
2021 Q4	$15K	Buy	+49,615	New	+$15.7K	﹤0.01%	2989

HRT Financial's DMAQR Position: Q1 2024 in Review

HRT Financial sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 48,400 shares — an estimated $14K sold.

HRT Financial first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $15K in Q4 2021. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

HRT Financial reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
HRT Financial sold 48,400 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $14K.
HRT Financial first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
HRT Financial's Deep Medicine Acquisition Corp. Rights position peaked at $15K in Q4 2021.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.